Siemens' gets US nod for shock wave therapy:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Siemens Medical Solutions' SONOCUR basic, a low-energy extracorporeal shock wave therapy system for treating lateral epicondylitis, a condition commonly known as tennis elbow. The company's multicentre, 114-patient, US clinical trial showed that 64% of patients treated with the system achieved at least a 50% reduction in pain at a 12-week follow-up. The trial, said the company, demonstrated that treatment with the device can provide a noninvasive alternative to surgery for patients who have failed to respond to conventional therapies.